Stock listing
Tradegate:4E2 Relmada Therapeutics, Inc. Aktie
German listing (Tradegate) of Relmada Therapeutics, Inc. · home listing NASDAQ:RLMD
Follow Relmada Therapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:RLMD
$3.58 USD +0.14 (+4.1%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:RLMD
- Day range
- $3.30 – $3.66 USDOct 30, 2026
- Volume
- 1.41M sharesOct 30, 2026
- Market cap
- $381.9M USDAt the close on Oct 30, 2026 · price × 106.7M shares outstanding
- 52-week range
- $2.15 – $8.00 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $5.34M USDMedian day 1.20M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:RLMD · Home | $3.58 USD | +0.14 (+4.1%) | 1,413,751 | $3.42 | $3.655 | $3.30 | $3.44 | Close on Oct 30, 2026 |
| Frankfurt:4E2 | €2.90 EUR | +0.14 (+5.1%) | — | €2.90 | €2.90 | €2.90 | €2.76 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:RLMD · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $3.58 | +0.14 | +4.1% | $3.42 | $3.655 | $3.30 | 1,413,751 | |
| $3.44 | +0.09 | +2.7% | $3.38 | $3.485 | $3.29 | 1,609,780 | |
| $3.35 | +0.14 | +4.4% | $3.21 | $3.36 | $3.18 | 1,614,697 | |
| $3.21 | -0.02 | -0.6% | $3.22 | $3.33 | $3.175 | 1,673,657 | |
| $3.23 | -0.04 | -1.2% | $3.30 | $3.305 | $3.215 | 775,829 | |
| $3.27 | -0.02 | -0.6% | $3.26 | $3.335 | $3.18 | 1,100,741 | |
| $3.29 | +0.08 | +2.5% | $3.27 | $3.41 | $3.15 | 6,281,293 | |
| $3.21 | -0.15 | -4.5% | $3.35 | $3.395 | $3.19 | 1,720,536 | |
| $3.36 | +0.20 | +6.3% | $3.17 | $3.395 | $3.16 | 740,282 | |
| $3.16 | +0.06 | +1.9% | $3.11 | $3.21 | $3.075 | 746,309 | |
| $3.10 | -0.10 | -3.1% | $3.21 | $3.29 | $3.07 | 1,279,415 | |
| $3.20 | -0.04 | -1.2% | $3.27 | $3.35 | $3.185 | 909,041 | |
| $3.24 | -0.12 | -3.6% | $3.31 | $3.37 | $3.195 | 1,354,317 | |
| $3.36 | -0.15 | -4.3% | $3.50 | $3.55 | $3.355 | 1,424,367 | |
| $3.51 | +0.12 | +3.5% | $3.39 | $3.535 | $3.315 | 1,423,670 | |
| $3.39 | +0.22 | +6.9% | $3.18 | $3.535 | $3.155 | 1,730,502 | |
| $3.17 | -0.08 | -2.5% | $3.23 | $3.32 | $3.10 | 1,886,414 | |
| $3.25 | -0.03 | -0.9% | $3.26 | $3.355 | $3.24 | 1,497,317 | |
| $3.28 | -0.20 | -5.7% | $3.50 | $3.50 | $3.265 | 1,735,689 | |
| $3.48 | -0.12 | -3.3% | $3.60 | $3.70 | $3.415 | 1,282,546 | |
| $3.60 | -0.06 | -1.6% | $3.72 | $3.73 | $3.60 | 1,209,548 | |
| $3.66 | -0.11 | -2.9% | $3.73 | $3.80 | $3.65 | 1,358,477 | |
| $3.77 | +0.04 | +1.1% | $3.78 | $3.845 | $3.72 | 999,525 | |
| $3.73 | -0.06 | -1.6% | $3.82 | $3.89 | $3.695 | 863,545 | |
| $3.79 | -0.04 | -1.0% | $3.80 | $3.855 | $3.71 | 986,628 | |
| $3.83 | +0.02 | +0.5% | $3.81 | $3.87 | $3.73 | 1,311,049 | |
| $3.81 | +0.03 | +0.8% | $3.74 | $3.875 | $3.66 | 1,325,332 | |
| $3.78 | -0.46 | -10.8% | $4.26 | $4.26 | $3.77 | 1,130,083 | |
| $4.24 | +0.08 | +1.9% | $4.16 | $4.27 | $4.145 | 662,654 | |
| $4.16 | +0.04 | +1.0% | $4.13 | $4.235 | $4.075 | 552,734 | |
| $4.12 | -0.08 | -1.9% | $4.15 | $4.17 | $4.06 | 2,069,829 | |
| $4.20 | -0.02 | -0.5% | $4.28 | $4.39 | $4.18 | 772,911 | |
| $4.22 | -0.22 | -5.0% | $4.45 | $4.572 | $4.205 | 824,376 | |
| $4.44 | 0.00 | 0.0% | $4.44 | $4.495 | $4.30 | 1,998,635 | |
| $4.44 | -0.08 | -1.8% | $4.52 | $4.56 | $4.42 | 1,264,731 | |
| $4.52 | +0.45 | +11.1% | $4.60 | $4.65 | $4.295 | 2,629,279 | |
| $4.07 | -0.02 | -0.5% | $4.25 | $4.25 | $4.00 | 2,808,981 | |
| $4.09 | -0.16 | -3.8% | $4.24 | $4.28 | $4.09 | 1,590,041 | |
| $4.25 | -0.18 | -4.1% | $4.40 | $4.425 | $4.13 | 1,697,806 | |
| $4.43 | +0.06 | +1.4% | $4.35 | $4.44 | $4.32 | 675,555 | |
| $4.37 | -0.17 | -3.7% | $4.55 | $4.58 | $4.33 | 847,511 | |
| $4.54 | +0.08 | +1.8% | $4.54 | $4.593 | $4.365 | 1,416,552 | |
| $4.46 | +0.10 | +2.3% | $4.31 | $4.51 | $4.31 | 944,057 | |
| $4.36 | +0.03 | +0.7% | $4.31 | $4.395 | $4.285 | 628,242 | |
| $4.33 | -0.19 | -4.2% | $4.51 | $4.53 | $4.32 | 678,358 | |
| $4.52 | -0.03 | -0.7% | $4.53 | $4.58 | $4.485 | 496,494 | |
| $4.55 | -0.04 | -0.9% | $4.57 | $4.60 | $4.46 | 476,693 | |
| $4.59 | +0.01 | +0.2% | $4.63 | $4.725 | $4.57 | 1,025,383 | |
| $4.58 | -0.05 | -1.1% | $4.64 | $4.64 | $4.375 | 935,748 | |
| $4.63 | -0.01 | -0.2% | $4.68 | $4.76 | $4.54 | 985,172 | |
| $4.64 | -0.19 | -3.9% | $4.74 | $4.79 | $4.55 | 1,033,935 | |
| $4.83 | -0.02 | -0.4% | $4.94 | $4.98 | $4.79 | 595,935 | |
| $4.85 | +0.08 | +1.7% | $4.75 | $4.86 | $4.71 | 751,699 | |
| $4.77 | -0.03 | -0.6% | $4.75 | $4.84 | $4.70 | 955,951 | |
| $4.80 | +0.05 | +1.1% | $4.74 | $4.835 | $4.68 | 925,432 | |
| $4.75 | +0.03 | +0.6% | $4.74 | $4.89 | $4.655 | 1,250,294 | |
| $4.72 | +0.25 | +5.6% | $4.52 | $4.81 | $4.51 | 1,663,026 | |
| $4.47 | -0.07 | -1.5% | $4.55 | $4.63 | $4.35 | 2,140,758 | |
| $4.54 | -0.40 | -8.1% | $4.91 | $4.935 | $4.505 | 1,806,338 | |
| $4.94 | -0.43 | -8.0% | $5.445 | $5.55 | $4.87 | 2,125,224 | |
| $5.37 | -0.07 | -1.3% | $5.44 | $5.575 | $5.32 | 984,259 | |
| $5.44 | -0.03 | -0.5% | $5.51 | $5.54 | $5.325 | 827,307 | |
| $5.47 | +0.17 | +3.2% | $5.33 | $5.555 | $5.33 | 1,196,776 | |
| $5.30 | -0.01 | -0.2% | $5.26 | $5.46 | $5.06 | 1,073,356 | |
| $5.31 | -0.04 | -0.7% | $5.38 | $5.40 | $5.00 | 1,717,951 | |
| $5.35 | +0.21 | +4.1% | $5.22 | $5.43 | $5.19 | 940,061 |
- Ticker
- Tradegate:4E2
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Tradegate
- Currency
- EUR
What changed lately
Latest news release · Sep 1, 2026
Relmada Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference
Latest earnings call · Aug 6, 2026
Relmada Therapeutics (NASDAQ:RLMD) Q2 2026 Earnings Call
Replay and transcript
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 32 slides
Calls
Replays
Relmada Therapeutics (NASDAQ:RLMD) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 4:30 PM ET
Watch TranscriptRelmada Therapeutics (NASDAQ:RLMD) Q1 2026 Earnings Call
Tue, May 12, 2026 · 4:30 PM ET
Watch TranscriptRelmada Therapeutics (NASDAQ:RLMD) Q4 2025 Earnings Call
Thu, Mar 19, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Relmada Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference
Sep 1, 2026
Closed $4.46 (+2.3%) on Sep 1, 2026
Relmada Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 6, 2026
Closed $4.94 (-8.0%) on Aug 7, 2026
Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer
Jul 28, 2026
Closed $5.23 (+0.6%) on Jul 28, 2026
Relmada Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
Jul 16, 2026
Closed $5.46 (-12.1%) on Jul 16, 2026
Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes
Jun 29, 2026
Closed $6.98 (+4.3%) on Jun 29, 2026
Relmada Therapeutics Appoints CNS Drug Development Veteran Michael Quirk as Senior Advisor for Sepranolone Program
Jun 11, 2026
Closed $6.52 (+2.2%) on Jun 11, 2026
Relmada Therapeutics to Present at the Jefferies Global Healthcare Conference
May 28, 2026
Closed $7.25 (-0.1%) on May 28, 2026
Relmada Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
May 12, 2026
Closed $7.49 (+0.5%) on May 13, 2026
Relmada Therapeutics to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026
May 6, 2026
Closed $7.86 (+6.9%) on May 6, 2026
Relmada Therapeutics to Present NDV-01 Abstracts at AUA2026
May 5, 2026
Closed $7.35 (-0.8%) on May 5, 2026
Decks
Investor Presentation (August 2026)
Investor deck · 32 slides · August 2026
Investor Presentation (May 2026)
Investor deck · 40 slides · May 12, 2026
Investor Presentation (March 2026)
Investor deck · 40 slides · Mar 20, 2026
Technical Presentation (March 2026)
Technical · 12 slides · Mar 9, 2026
Relmada Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 21 in the last 12 months · 107 in all · newest Sep 1, 2026 · oldest 2019
- Calls
- 23 calls with a replay · 23 with a transcript · latest Aug 6, 2026
- Decks
- 34 decks · latest August 2026
Where Relmada Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:RLMD · Home listing | NASDAQ | United States | USD |
| gettex:4E2 | gettex | Germany | EUR |
| LS Exchange:A2PSZF | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2PSZF | Lang & Schwarz | Germany | EUR |
| BOATS:RLMD | BOATS | United States | USD |
| Frankfurt:4E2 | Frankfurt | Germany | EUR |
| Tradegate:4E2 · This page | Tradegate | Germany | EUR |
| Dusseldorf:4E2 | Dusseldorf | Germany | EUR |
| Hamburg:4E2 | Hamburg | Germany | EUR |
| Munich:4E2 | Munich | Germany | EUR |
| Stuttgart:4E2 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Relmada Therapeutics, Inc.